Background: Antibiotic treatment may disturb the resistance of gastrointestinal flora to
colonization. This may result in complications, the most serious of which is Clostridium …

Non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, enteric or other systemic
infections, and stress have all been reported to be potential triggers of inflammatory bowel …

Background Clinicians who treat patients with Clostridium difficile–associated diarrhea
(CDAD) in Quebec, Canada, have noted an apparent increase in the proportion of patients …

Toxigenic Clostridium difficile strains produce two toxins (TcdA and TcdB) during the
stationary phase of growth and are the leading cause of antibiotic-associated diarrhea. C …

Background. Clostridium difficile infection (CDI) is the most frequent cause of health care-
associated infectious diarrhea in industrialized countries. The only previous report …

BACKGROUND: Antibiotic-associated diarrhea is an important problem in hospitalized
patients. The use of probiotics is gaining interest in the scientific community as a potential …

Clostridium difficile is a leading cause of antibiotic-associated diarrhea, and a significant
etiologic agent of healthcare-associated infections. The mechanisms of attachment and host …

Background: The recent increase in the number and severity of cases of nosocomial
Clostridium difficile-associated diarrhea (CDAD) has prompted interest in the use of …

Spores of Clostridium difficile play a key role in the dissemination of this important human
pathogen, and until recently little has been known of their functional characteristics. Genes …

Clostridium difficile, a proteolytic strict anaerobe, has emerged as a clinically significant
nosocomial pathogen in recent years. Pathogenesis is due to the production of lethal toxins …